Abstract #505: Phase III, randomized, double-blind, placebo-controlled multicenter trial of daily everolimus plus weekly trastuzumab and vinorelbine in trastuzumab-resistant, advanced breast cancer

Video interview with Dr. Ron Burkes with the latest updates on Lung Cancer from ASCO 2013, covering abstracts 8027, 8028, 8030, 8031, 8033, 8034, 8036, presented during the Poster Discussion Session,

Video interview with Dr. Scott Berry with CAIRO-3 Trial Updates from ASCO 2013.

Audio interview with Dr. Karim Fizazi the Results of GETUG 13, at ASCO 2013.

Video interview with Dr. Krishnansu Tewari on Abstract 3#: Incorporation of bevacizumab in the treatment of recurrent and metastatic cervical cancer: A phase III randomized trial of the Gynecologic On

Video interview with Dr. Volker Heinemann with the latest updates on FIRE-3 trial from ASCO 2013.

Abstract #5: aTTom: Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years in 6,953 women with early breast cancer.

Abstract #CRA1008: S0221: Comparison of two schedules of paclitaxel as adjuvant therapy for breast cancer: S0221 is a SWOG-coordinated phase III adjuvant chemotherapy intergroup trial in node-positive

Abstract #505: Phase III, randomized, double-blind, placebo-controlled multicenter trial of daily everolimus plus weekly trastuzumab and vinorelbine in trastuzumab-resistant, advanced breast cancer

Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer patients: Final analysis of the EORTC AMAROS trial (10981/22023)